Comparison of the Effectiveness of Treadmill-Based Walking and Dual-Task Walking Training in Alzheimer's Disease

Recruiting N/A Interventional Study
Alzheimer' Disease Dementia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
46 (estimated)
Sponsor
Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Alzheimer's disease is a neurodegenerative condition that affects both cognitive and motor functions, making daily life activities more challenging. Motor functions, especially walking and balance, begin to deteriorate early in the disease and progress in parallel with cognitive decline. Dual-task performance, which refers to the ability to perform both motor and cognitive tasks simultaneously, si…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of Alzheimer's disease according to the NINCDS-ADRDA criteria by a neurologist, 2. In the early or middle stages of the disease according to the Clinical Dementia Rating Scale (CDR), 3. Receiving medical treatment for Alzheimer's disease (e.g., cholinesterase inhibi…
Contacts

Kübra Nur Menengiç, MSc

+90 216 547 26 00

kmenengic@gmail.com

CONTACT

İpek Yeldan, Prof. Dr.

+90 212 866 37 00

ipekyeldan@gmail.com

CONTACT